Dechra Pharmaceuticals launches private placement of unsecured notes
14th Jul 2022 07:32
(Sharecast News) - Drugmaker Dechra Pharmaceuticals has launched a private placement of €50.0m seven-year and €100.0m ten-year new senior unsecured notes.
Read moreDechra revenues up double-digits in 'another record year'
11th Jul 2022 07:12
(Sharecast News) - Veterinary pharmaceutical business Dechra said on Monday that revenues had "increased strongly" during a "record" twelve months ended 30 June, up 14% at constant currency and 12% at actual exchange rates.
Read moreRBC Capital ups Dechra to 'outperform', cites attractive entry point
5th Jul 2022 07:22
(Sharecast News) - RBC Capital Markets upgraded Dechra Pharmaceuticals on Tuesday to 'outperform' from 'sector perform', citing an attractive entry point.
Read moreLiberum upgrades Dechra after share price weakness
23rd Feb 2022 07:59
(Sharecast News) - Liberum upgraded Dechra Pharmaceuticals to 'hold' from 'sell' and lifted the price target to 4,020p from 4,000p on Wednesday following weakness in the share price.
Read moreLiberum upgrades Dechra after share price weakness
23rd Feb 2022 07:59
(Sharecast News) - Liberum upgraded Dechra Pharmaceuticals to 'hold' from 'sell' and lifted the price target to 4,020p from 4,000p on Wednesday following weakness in the share price.
Read moreDechra Pharmaceuticals lifts interim dividend as profits rise
21st Feb 2022 08:04
(Sharecast News) - Dechra Pharmaceuticals lifted its interim dividend on Monday as it posted a jump in profit and revenue.
Read moreDechra sees full year at upper end of management expectations
13th Jan 2022 08:09
(Sharecast News) - Dechra Pharmaceuticals said on Thursday that the full-year outlook was towards the upper end of management expectations as it reported a jump in first-half revenues.
Read moreDechra acquires worldwide rights to canine lymphoma treatment
11th Jan 2022 23:42
(Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine lymphoma from Anivive Lifesciences.
Read moreDechra slumps as Exane highlights 'punchy valuation'
4th Jan 2022 11:47
(Sharecast News) - Dechra Pharmaceuticals was under the cosh on Tuesday after Exane BNP Paribas initiated coverage of the stock at 'neutral' on valuation grounds.
Read moreDechra Pharma selects Alison Platt as next chair
19th Nov 2021 07:34
(Sharecast News) - Dechra Pharmaceuticals has selected Alison Platt to chair the board when Tony Rice steps down at the end of 2021.
Read moreStrong US market underpins first quarter growth for Dechra
21st Oct 2021 08:13
(Sharecast News) - Dechra Pharmaceuticals described trading in the first quarter of its financial year as "strong" in an update on Thursday.
Read moreDirector dealings: Dechra director makes share sale
13th Sep 2021 16:03
(Sharecast News) - Dechra Pharmaceuticals revealed on Monday that director Tony Griffin had sold 17,500 ordinary shares in the FTSE 250-listed veterinary drugmaker.
Read moreLiberum cautious on durability of Covid boost for Dechra Pharmaceuticals
7th Sep 2021 13:29
(Sharecast News) - Analysts at Liberum hiked their target price for shares of Dechra Pharmaceuticals but kept their recommendation at 'sell', telling clients that they struggled to justify such a lofty valuation.
Read moreDechra Pharma profits up as pet care rises during lockdown
6th Sep 2021 07:01
(Sharecast News) - Veterinary drug maker Dechra Pharmaceuticals reported a surge in profits and lifted its dividend as people spent more on pet welfare during Covid-19 lockdowns.
Read moreDechra Pharma profits up as pet care rises during lockdown
6th Sep 2021 07:01
(Sharecast News) - Veterinary drug maker Dechra Pharmaceuticals reported a surge in profits and lifted its dividend as people spent more on pet welfare during Covid-19 lockdowns.
Read more